trending Market Intelligence /marketintelligence/en/news-insights/trending/ub5tq5yxr7pr7qgimwzilq2 content esgSubNav
In This List

Rakuten invests in Japanese genetic testing company Genesis

Case Study

A Sports League Maximizes Revenue from Media Rights

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Rakuten invests in Japanese genetic testing company Genesis

Japanese genetic testing company Genesis Healthcare Co. said Feb. 27 that online retailer Rakuten Inc. and Omron Healthcare Co. Ltd. invested in Genesis to bring its valuation to ¥42 billion.

The details of the investment were not disclosed. Genesis said that this was Rakuten's second investment in Genesis. The retailer bought about ¥1.4 billion worth of Genesis shares in August 2017.

As of Feb. 26, US$1 was equivalent to ¥106.92.